Margarita Montoya-Buelna
Overview
Explore the profile of Margarita Montoya-Buelna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Montoya-Buelna M, Ramirez-Lopez I, San Juan-Garcia C, Garcia-Regalado J, Millan-Sanchez M, De la Cruz-Mosso U, et al.
World J Hepatol
. 2024 Oct;
16(9):1211-1228.
PMID: 39351515
Extracellular vesicles (EVs) are small particles released by many cell types in different tissues, including the liver, and transfer specific cargo molecules from originating cells to receptor cells. This process...
2.
Montoya-Buelna M, Alvarado-Navarro A, Munoz-Valle J, Lopez-Roa R, Guerrero-Velazquez C, Fafutis-Morris M
J Infect Dev Ctries
. 2024 Jun;
18(5):770-778.
PMID: 38865403
Introduction: Studies in different populations have shown that single-nucleotide polymorphisms (SNPs) of tumor necrosis factor-alpha (TNFα) and TNF receptors 1 and 2 (TNFR1 and TNFR2) may be involved in the...
3.
Ruiz-Ballesteros A, Betancourt-Nunez A, Meza-Meza M, Rivera-Escoto M, Mora-Garcia P, Pesqueda-Cendejas K, et al.
Lupus
. 2024 May;
33(8):851-863.
PMID: 38709772
Serum and dietary vitamin D could influence clinical disease activity and cardiometabolic outcomes in systemic lupus erythematosus (SLE). This study aimed to assess the relationship of serum and dietary vitamin...
4.
Pesqueda-Cendejas K, Rivera-Escoto M, Meza-Meza M, Campos-Lopez B, Parra-Rojas I, Montoya-Buelna M, et al.
Nutrients
. 2023 Feb;
15(4).
PMID: 36839394
Systemic lupus erythematosus (SLE) is a chronic pathology characterized by a bimodal mortality pattern attributed to clinical disease activity and cardiovascular disease (CVD). A complex interaction between traditional CVD risk...
5.
Campos-Lopez B, Meza-Meza M, Pesqueda-Cendejas K, Ruiz-Ballesteros A, Rivera-Escoto M, Vargas-Morales J, et al.
Lupus
. 2022 Dec;
32(2):270-283.
PMID: 36562214
Systemic lupus erythematosus (SLE) is the prototypical autoimmune disease considered as an independent risk factor for mortality by cardiovascular disease. Currently, uric acid is described as a novel biomarker associated...
6.
Meza-Meza M, Vizmanos B, Rivera-Escoto M, Ruiz-Ballesteros A, Pesqueda-Cendejas K, Parra-Rojas I, et al.
Genes (Basel)
. 2022 Nov;
13(11).
PMID: 36360253
Vitamin D (VD) deficiency is more frequent in systemic lupus erythematosus (SLE) patients than in control subjects (CS); genetic variants in the VD receptor () could contribute to the clinical...
7.
Pesqueda-Cendejas K, Parra-Rojas I, Meza-Meza M, Mora-Garcia P, Campos-Lopez B, Ruiz-Ballesteros A, et al.
Clin Rheumatol
. 2022 Nov;
42(3):761-772.
PMID: 36355253
Introduction: Systemic lupus erythematosus (SLE) is an autoimmune disease where genetic factors have been related to SLE susceptibility and disease severity. CRP polymorphisms have been associated with high C-reactive protein...
8.
Pesqueda-Cendejas K, Parra-Rojas I, Mora-Garcia P, Montoya-Buelna M, Ruiz-Ballesteros A, Meza-Meza M, et al.
J Clin Med
. 2022 Apr;
11(7).
PMID: 35407457
Systemic lupus erythematosus (SLE) patients have a higher frequency of cardiovascular risk factors such as high C-reactive protein (CRP) levels than the general population. CRP is considered a cardiovascular disease...
9.
Campos-Lopez B, Meza-Meza M, Parra-Rojas I, Ruiz-Ballesteros A, Vizmanos-Lamotte B, Munoz-Valle J, et al.
Clin Immunol
. 2020 Nov;
222:108637.
PMID: 33232825
Cardiometabolic status is a key factor in mortality by cardiovascular disease (CVD) in systemic lupus erythematosus (SLE). This study evaluated the association of cardiometabolic risk status with clinical activity and...
10.
Macias-Barragan J, Montoya-Buelna M, Enciso-Vargas M, Alvarado-Ruiz L, Oceguera-Contreras E, Guerra-Renteria A, et al.
Immunol Invest
. 2020 Oct;
51(3):480-495.
PMID: 33115277
Background: Psoriasis (Ps) is an autoimmune dermatosis. Previous studies have shown an association between genes and susceptibility to some clinical variants of Ps. Therefore, we conducted an exhaustive systematic review...